TORRENT PHARMACEUTICALS LTD. - 500420 - Audio Recording Of Conference Call With Analysts / Investors On Financial Results For The Quarter Ended 30Th June, 2022
In continuation of our letter dated 21-Jul-22 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of Conference call with Analysts / Investors on Financial Results of the Company for the quarter ended 30th June, 2022, has been placed on the Company's website at https://www.torrentpharma.com/pdf/investors/Audio_Recording30062022.mp330-07-2022